model-based robust multiarray average (rma) algorithm (Partek)
90
Structured Review
Partek
model-based robust multiarray average (rma) algorithm
Model Based Robust Multiarray Average (Rma) Algorithm, supplied by Partek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/model-based+robust+multiarray+average+(rma)+algorithm/robust+multiarray+average++rma++algorithm/pm28209612-103-11-20
Average 90 stars, based on 1 article reviews
Model Based Robust Multiarray Average (Rma) Algorithm, supplied by Partek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/model-based+robust+multiarray+average+(rma)+algorithm/robust+multiarray+average++rma++algorithm/pm28209612-103-11-20
Average 90 stars, based on 1 article reviews
model-based robust multiarray average (rma) algorithm - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Derivative Assay:Article Title: miRNA-520f Reverses Epithelial-to-Mesenchymal Transition by Targeting ADAM9 and TGFBR2 . Article Snippet: 2 Reversing epithelial-to-mesenchymal transition (EMT) in cancer cells has been widely considered as an approach to combat cancer progression and therapeutic resistance, but a limited number of broadly comprehensive investigations of microRNAs involved in this process have been conducted.. In this study, we screened a library of 1120 microRNA for their ability to transcriptionally activate the E-cadherin gene CDH1 in a promoter reporter assay as a measure of EMT reversal.. By this approach, we defined miR-520f as a novel EMT-reversing microRNA. miR-520f expression was sufficient to restore endogenous levels of E-cadherin in cancer cell lines exhibiting strong or intermediate mesenchymal phenotypes. Article Title: Ex-vivo perfusion as a successful strategy for reduction of ischemia-reperfusion injury in prolonged muscle flap preservation - A gene expression study. Article Snippet: Introduction: With the introduction of vascularized composite allotransplantation (VCA) as new surgical technique, the need arose for strategies that could safely prolong graft preservation.. Ex-vivo machine perfusion is a promising technique and is currently applied in solid organ transplantation.. There is still limited evidence in the field of VCA and free flap transplantation. Software:Article Title: miRNA-520f Reverses Epithelial-to-Mesenchymal Transition by Targeting ADAM9 and TGFBR2 . Article Snippet: 2 Reversing epithelial-to-mesenchymal transition (EMT) in cancer cells has been widely considered as an approach to combat cancer progression and therapeutic resistance, but a limited number of broadly comprehensive investigations of microRNAs involved in this process have been conducted.. In this study, we screened a library of 1120 microRNA for their ability to transcriptionally activate the E-cadherin gene CDH1 in a promoter reporter assay as a measure of EMT reversal.. By this approach, we defined miR-520f as a novel EMT-reversing microRNA. miR-520f expression was sufficient to restore endogenous levels of E-cadherin in cancer cell lines exhibiting strong or intermediate mesenchymal phenotypes. Article Title: Ex-vivo perfusion as a successful strategy for reduction of ischemia-reperfusion injury in prolonged muscle flap preservation - A gene expression study. Article Snippet: Introduction: With the introduction of vascularized composite allotransplantation (VCA) as new surgical technique, the need arose for strategies that could safely prolong graft preservation.. Ex-vivo machine perfusion is a promising technique and is currently applied in solid organ transplantation.. There is still limited evidence in the field of VCA and free flap transplantation. Gene Expression:Article Title: miRNA-520f Reverses Epithelial-to-Mesenchymal Transition by Targeting ADAM9 and TGFBR2 . Article Snippet: 2 Reversing epithelial-to-mesenchymal transition (EMT) in cancer cells has been widely considered as an approach to combat cancer progression and therapeutic resistance, but a limited number of broadly comprehensive investigations of microRNAs involved in this process have been conducted.. In this study, we screened a library of 1120 microRNA for their ability to transcriptionally activate the E-cadherin gene CDH1 in a promoter reporter assay as a measure of EMT reversal.. By this approach, we defined miR-520f as a novel EMT-reversing microRNA. miR-520f expression was sufficient to restore endogenous levels of E-cadherin in cancer cell lines exhibiting strong or intermediate mesenchymal phenotypes. Article Title: Ex-vivo perfusion as a successful strategy for reduction of ischemia-reperfusion injury in prolonged muscle flap preservation - A gene expression study. Article Snippet: Introduction: With the introduction of vascularized composite allotransplantation (VCA) as new surgical technique, the need arose for strategies that could safely prolong graft preservation.. Ex-vivo machine perfusion is a promising technique and is currently applied in solid organ transplantation.. There is still limited evidence in the field of VCA and free flap transplantation. |